How I missed one of the hottest recent IPOs

Because of the parlor game of international finance, I focused on macro and international concerns instead of remaining US-stock-centric.

By Jim Cramer Jul 2, 2013 10:00AM

thestreet logo

A Noodles & Company restaurant (Noodles & Company via Facebook)Are you as tired as I am of the parlor game about what's driving this market? When I wake up these days, I look at China to get my usual dose of disappointment. Then I see how manipulated Japan is -- and in what direction it went -- and then I examine how horrible Europe is, and then I read stories about how the latest Federal Reserve guessing game is going. Only then do I look at how stocks are doing.


I am told to do all of this, in that order, by everyone I listen to. Some have told me -- people who are older and smarter than I am -- that, in order to figure out where the U.S. market will go, all I have to do is monitor Japan. Others say that China is pretty much in charge these days, and if China's banking system implodes, all bets are off. They say that, given the see-through nature of all those buildings in the major cities in China, that country is a ticking time bomb, especially if it needs to repatriate assets. Then others tell me that, if Spain and Italy turn and Europe gets going again, that means we'll be able to see a turn in China, which therefore means a turn here in the U.S.


But I keep thinking about Noodles (NDLS) and Onyx Pharma (ONXX). That's right -- I keep thinking about what would have been if I'd begun looking at things from the perspective of who has the best new restaurant chain and who has the best growth in biotech. I keep thinking, in other words, that I would now be making a heck of a lot more money if I'd been U.S.-stock-centric.


Fortunately, I had been able to see that Onyx could be a valuable piece of property. But that's only because I know Celgene (CELG) and the challenge that Onyx presents to it in multiple myeloma treatment -- and also because my mother died of kidney cancer, which gave me a personal insight that drew me to Onyx's Nexavar franchise.


But Noodles is infuriating me. Just infuriating -- and I am blaming it directly on the parlor game of international finance. I hadn't focused on this initial public offering because there was "too much going on," and because I was too worried about the 10-year U.S. Treasury. I knew this company may be the hottest concept out there, because I have a noodle bar next to me -- ramen-based -- that you can't get into, and which The New York Times says is the hottest trend. I know that the Asian ShopHouse from Chipotle (CMG) seems stillborn, but the concept is a winning one. From researching Chipotle, I even knew the gents who started the joint.

But the Noodles IPO itself? Totally lost in the thicket that is the handwringing about whether the Fed is really tightening.


This is a bad sign for a stock-picker like me. We have to take advantage of the free money wherever we can find it, and that money has been in the IPO market. The Noodles deal was precisely the kind that bankers give you when you're fed up and when IPOs are being cancelled. It was a non-New York deal, meaning you had to get outside yourself, or at least outside the city, in order to know what the chain was like. Yet no one I know even talked about it because of the Fed obsession.


It was a real wake-up call that we need to get the international focus tamped and the U.S. focus ramped, no matter what -- because that's where the money is. Everything else, while not a distraction, does keep you from thinking about what really moves stocks, instead of what the old and new pros proclaim is calling the tune. You don't find Noodles by looking at the yen. You don't find Onyx by guessing about European fund flows or U.S. gross domestic product. If only life were that easy.

 

Cramer

 


Jim Cramer is a co-founder of TheStreet and contributes daily market commentary to the financial news network's sites. Follow his trades for Action Alerts PLUS, which Cramer co-manages as a charitable trust and has no positions in stocks mentioned.  

 

 

More from TheStreet.com

48Comments
Jul 2, 2013 10:43AM
avatar

thestreet logo

A Noodles & Company restaurant (Noodles & Company via Facebook)Are you as tired as I am of the parlor game about what's driving this market? When I wake up these days, I look at China to get my usual dose of disappointment. Then I see how manipulated Japan is -- and in what direction it went -- and then I examine how horrible Europe is, and then I read stories about how the latest Federal Reserve guessing game is going. Only then do I look at how stocks are doing.


I am told to do all of this, in that order, by everyone I listen to. Some have told me -- people who are older and smarter than I am -- that, in order to figure out where the U.S. market will go, all I have to do is monitor Japan. Others say that China is pretty much in charge these days, and if China's banking system implodes, all bets are off. They say that, given the see-through nature of all those buildings in the major cities in China, that country is a ticking time bomb, especially if it needs to repatriate assets. Then others tell me that, if Spain and Italy turn and Europe gets going again, that means we'll be able to see a turn in China, which therefore means a turn here in the U.S.


But I keep thinking about Noodles (NDLS) and Onyx Pharma (ONXX). That's right -- I keep thinking about what would have been if I'd begun looking at things from the perspective of who has the best new restaurant chain and who has the best growth in biotech. I keep thinking, in other words, that I would now be making a heck of a lot more money if I'd been U.S.-stock-centric.


Fortunately, I had been able to see that Onyx could be a valuable piece of property. But that's only because I know Celgene (CELG) and the challenge that Onyx presents to it in multiple myeloma treatment -- and also because my mother died of kidney cancer, which gave me a personal insight that drew me to Onyx's Nexavar franchise.


But Noodles is infuriating me. Just infuriating -- and I am blaming it directly on the parlor game of international finance. I hadn't focused on this initial public offering because there was "too much going on," and because I was too worried about the 10-year U.S. Treasury. I knew this company may be the hottest concept out there, because I have a noodle bar next to me -- ramen-based -- that you can't get into, and which The New York Times says is the hottest trend. I know that the Asian ShopHouse from Chipotle (CMG) seems stillborn, but the concept is a winning one. From researching Chipotle, I even knew the gents who started the joint.

But the Noodles IPO itself? Totally lost in the thicket that is the handwringing about whether the Fed is really tightening.


This is a bad sign for a stock-picker like me. We have to take advantage of the free money wherever we can find it, and that money has been in the IPO market. The Noodles deal was precisely the kind that bankers give you when you're fed up and when IPOs are being cancelled. It was a non-New York deal, meaning you had to get outside yourself, or at least outside the city, in order to know what the chain was like. Yet no one I know even talked about it because of the Fed obsession.


It was a real wake-up call that we need to get the international focus tamped and the U.S. focus ramped, no matter what -- because that's where the money is. Everything else, while not a distraction, does keep you from thinking about what really moves stocks, instead of what the old and new pros proclaim is calling the tune. You don't find Noodles by looking at the yen. You don't find Onyx by guessing about European fund flows or U.S. gross domestic product. If only life were that easy.

 

Cramer

 


Jim Cramer is a co-founder of TheStreet and contributes daily market commentary to the financial news network's sites. Follow his trades for Action Alerts PLUS, which Cramer co-manages as a charitable trust and has no positions in stocks mentioned.  

 

 

More from TheStreet.com

Jul 2, 2013 10:25AM
avatar

thestreet logo

A Noodles & Company restaurant (Noodles & Company via Facebook)Are you as tired as I am of the parlor game about what's driving this market? When I wake up these days, I look at China to get my usual dose of disappointment. Then I see how manipulated Japan is -- and in what direction it went -- and then I examine how horrible Europe is, and then I read stories about how the latest Federal Reserve guessing game is going. Only then do I look at how stocks are doing.


I am told to do all of this, in that order, by everyone I listen to. Some have told me -- people who are older and smarter than I am -- that, in order to figure out where the U.S. market will go, all I have to do is monitor Japan. Others say that China is pretty much in charge these days, and if China's banking system implodes, all bets are off. They say that, given the see-through nature of all those buildings in the major cities in China, that country is a ticking time bomb, especially if it needs to repatriate assets. Then others tell me that, if Spain and Italy turn and Europe gets going again, that means we'll be able to see a turn in China, which therefore means a turn here in the U.S.


But I keep thinking about Noodles (NDLS) and Onyx Pharma (ONXX). That's right -- I keep thinking about what would have been if I'd begun looking at things from the perspective of who has the best new restaurant chain and who has the best growth in biotech. I keep thinking, in other words, that I would now be making a heck of a lot more money if I'd been U.S.-stock-centric.


Fortunately, I had been able to see that Onyx could be a valuable piece of property. But that's only because I know Celgene (CELG) and the challenge that Onyx presents to it in multiple myeloma treatment -- and also because my mother died of kidney cancer, which gave me a personal insight that drew me to Onyx's Nexavar franchise.


But Noodles is infuriating me. Just infuriating -- and I am blaming it directly on the parlor game of international finance. I hadn't focused on this initial public offering because there was "too much going on," and because I was too worried about the 10-year U.S. Treasury. I knew this company may be the hottest concept out there, because I have a noodle bar next to me -- ramen-based -- that you can't get into, and which The New York Times says is the hottest trend. I know that the Asian ShopHouse from Chipotle (CMG) seems stillborn, but the concept is a winning one. From researching Chipotle, I even knew the gents who started the joint.

But the Noodles IPO itself? Totally lost in the thicket that is the handwringing about whether the Fed is really tightening.


This is a bad sign for a stock-picker like me. We have to take advantage of the free money wherever we can find it, and that money has been in the IPO market. The Noodles deal was precisely the kind that bankers give you when you're fed up and when IPOs are being cancelled. It was a non-New York deal, meaning you had to get outside yourself, or at least outside the city, in order to know what the chain was like. Yet no one I know even talked about it because of the Fed obsession.


It was a real wake-up call that we need to get the international focus tamped and the U.S. focus ramped, no matter what -- because that's where the money is. Everything else, while not a distraction, does keep you from thinking about what really moves stocks, instead of what the old and new pros proclaim is calling the tune. You don't find Noodles by looking at the yen. You don't find Onyx by guessing about European fund flows or U.S. gross domestic product. If only life were that easy.

 

Cramer

 


Jim Cramer is a co-founder of TheStreet and contributes daily market commentary to the financial news network's sites. Follow his trades for Action Alerts PLUS, which Cramer co-manages as a charitable trust and has no positions in stocks mentioned.  

 

 

More from TheStreet.com

Jul 2, 2013 1:46PM
avatar

thestreet logo

A Noodles & Company restaurant (Noodles & Company via Facebook)Are you as tired as I am of the parlor game about what's driving this market? When I wake up these days, I look at China to get my usual dose of disappointment. Then I see how manipulated Japan is -- and in what direction it went -- and then I examine how horrible Europe is, and then I read stories about how the latest Federal Reserve guessing game is going. Only then do I look at how stocks are doing.


I am told to do all of this, in that order, by everyone I listen to. Some have told me -- people who are older and smarter than I am -- that, in order to figure out where the U.S. market will go, all I have to do is monitor Japan. Others say that China is pretty much in charge these days, and if China's banking system implodes, all bets are off. They say that, given the see-through nature of all those buildings in the major cities in China, that country is a ticking time bomb, especially if it needs to repatriate assets. Then others tell me that, if Spain and Italy turn and Europe gets going again, that means we'll be able to see a turn in China, which therefore means a turn here in the U.S.


But I keep thinking about Noodles (NDLS) and Onyx Pharma (ONXX). That's right -- I keep thinking about what would have been if I'd begun looking at things from the perspective of who has the best new restaurant chain and who has the best growth in biotech. I keep thinking, in other words, that I would now be making a heck of a lot more money if I'd been U.S.-stock-centric.


Fortunately, I had been able to see that Onyx could be a valuable piece of property. But that's only because I know Celgene (CELG) and the challenge that Onyx presents to it in multiple myeloma treatment -- and also because my mother died of kidney cancer, which gave me a personal insight that drew me to Onyx's Nexavar franchise.


But Noodles is infuriating me. Just infuriating -- and I am blaming it directly on the parlor game of international finance. I hadn't focused on this initial public offering because there was "too much going on," and because I was too worried about the 10-year U.S. Treasury. I knew this company may be the hottest concept out there, because I have a noodle bar next to me -- ramen-based -- that you can't get into, and which The New York Times says is the hottest trend. I know that the Asian ShopHouse from Chipotle (CMG) seems stillborn, but the concept is a winning one. From researching Chipotle, I even knew the gents who started the joint.

But the Noodles IPO itself? Totally lost in the thicket that is the handwringing about whether the Fed is really tightening.


This is a bad sign for a stock-picker like me. We have to take advantage of the free money wherever we can find it, and that money has been in the IPO market. The Noodles deal was precisely the kind that bankers give you when you're fed up and when IPOs are being cancelled. It was a non-New York deal, meaning you had to get outside yourself, or at least outside the city, in order to know what the chain was like. Yet no one I know even talked about it because of the Fed obsession.


It was a real wake-up call that we need to get the international focus tamped and the U.S. focus ramped, no matter what -- because that's where the money is. Everything else, while not a distraction, does keep you from thinking about what really moves stocks, instead of what the old and new pros proclaim is calling the tune. You don't find Noodles by looking at the yen. You don't find Onyx by guessing about European fund flows or U.S. gross domestic product. If only life were that easy.

 

Cramer

 


Jim Cramer is a co-founder of TheStreet and contributes daily market commentary to the financial news network's sites. Follow his trades for Action Alerts PLUS, which Cramer co-manages as a charitable trust and has no positions in stocks mentioned.  

 

 

More from TheStreet.com

Jul 2, 2013 10:43AM
avatar

thestreet logo

A Noodles & Company restaurant (Noodles & Company via Facebook)Are you as tired as I am of the parlor game about what's driving this market? When I wake up these days, I look at China to get my usual dose of disappointment. Then I see how manipulated Japan is -- and in what direction it went -- and then I examine how horrible Europe is, and then I read stories about how the latest Federal Reserve guessing game is going. Only then do I look at how stocks are doing.


I am told to do all of this, in that order, by everyone I listen to. Some have told me -- people who are older and smarter than I am -- that, in order to figure out where the U.S. market will go, all I have to do is monitor Japan. Others say that China is pretty much in charge these days, and if China's banking system implodes, all bets are off. They say that, given the see-through nature of all those buildings in the major cities in China, that country is a ticking time bomb, especially if it needs to repatriate assets. Then others tell me that, if Spain and Italy turn and Europe gets going again, that means we'll be able to see a turn in China, which therefore means a turn here in the U.S.


But I keep thinking about Noodles (NDLS) and Onyx Pharma (ONXX). That's right -- I keep thinking about what would have been if I'd begun looking at things from the perspective of who has the best new restaurant chain and who has the best growth in biotech. I keep thinking, in other words, that I would now be making a heck of a lot more money if I'd been U.S.-stock-centric.


Fortunately, I had been able to see that Onyx could be a valuable piece of property. But that's only because I know Celgene (CELG) and the challenge that Onyx presents to it in multiple myeloma treatment -- and also because my mother died of kidney cancer, which gave me a personal insight that drew me to Onyx's Nexavar franchise.


But Noodles is infuriating me. Just infuriating -- and I am blaming it directly on the parlor game of international finance. I hadn't focused on this initial public offering because there was "too much going on," and because I was too worried about the 10-year U.S. Treasury. I knew this company may be the hottest concept out there, because I have a noodle bar next to me -- ramen-based -- that you can't get into, and which The New York Times says is the hottest trend. I know that the Asian ShopHouse from Chipotle (CMG) seems stillborn, but the concept is a winning one. From researching Chipotle, I even knew the gents who started the joint.

But the Noodles IPO itself? Totally lost in the thicket that is the handwringing about whether the Fed is really tightening.


This is a bad sign for a stock-picker like me. We have to take advantage of the free money wherever we can find it, and that money has been in the IPO market. The Noodles deal was precisely the kind that bankers give you when you're fed up and when IPOs are being cancelled. It was a non-New York deal, meaning you had to get outside yourself, or at least outside the city, in order to know what the chain was like. Yet no one I know even talked about it because of the Fed obsession.


It was a real wake-up call that we need to get the international focus tamped and the U.S. focus ramped, no matter what -- because that's where the money is. Everything else, while not a distraction, does keep you from thinking about what really moves stocks, instead of what the old and new pros proclaim is calling the tune. You don't find Noodles by looking at the yen. You don't find Onyx by guessing about European fund flows or U.S. gross domestic product. If only life were that easy.

 

Cramer

 


Jim Cramer is a co-founder of TheStreet and contributes daily market commentary to the financial news network's sites. Follow his trades for Action Alerts PLUS, which Cramer co-manages as a charitable trust and has no positions in stocks mentioned.  

 

 

More from TheStreet.com

Jul 2, 2013 2:19PM
avatar

thestreet logo

A Noodles & Company restaurant (Noodles & Company via Facebook)Are you as tired as I am of the parlor game about what's driving this market? When I wake up these days, I look at China to get my usual dose of disappointment. Then I see how manipulated Japan is -- and in what direction it went -- and then I examine how horrible Europe is, and then I read stories about how the latest Federal Reserve guessing game is going. Only then do I look at how stocks are doing.


I am told to do all of this, in that order, by everyone I listen to. Some have told me -- people who are older and smarter than I am -- that, in order to figure out where the U.S. market will go, all I have to do is monitor Japan. Others say that China is pretty much in charge these days, and if China's banking system implodes, all bets are off. They say that, given the see-through nature of all those buildings in the major cities in China, that country is a ticking time bomb, especially if it needs to repatriate assets. Then others tell me that, if Spain and Italy turn and Europe gets going again, that means we'll be able to see a turn in China, which therefore means a turn here in the U.S.


But I keep thinking about Noodles (NDLS) and Onyx Pharma (ONXX). That's right -- I keep thinking about what would have been if I'd begun looking at things from the perspective of who has the best new restaurant chain and who has the best growth in biotech. I keep thinking, in other words, that I would now be making a heck of a lot more money if I'd been U.S.-stock-centric.


Fortunately, I had been able to see that Onyx could be a valuable piece of property. But that's only because I know Celgene (CELG) and the challenge that Onyx presents to it in multiple myeloma treatment -- and also because my mother died of kidney cancer, which gave me a personal insight that drew me to Onyx's Nexavar franchise.


But Noodles is infuriating me. Just infuriating -- and I am blaming it directly on the parlor game of international finance. I hadn't focused on this initial public offering because there was "too much going on," and because I was too worried about the 10-year U.S. Treasury. I knew this company may be the hottest concept out there, because I have a noodle bar next to me -- ramen-based -- that you can't get into, and which The New York Times says is the hottest trend. I know that the Asian ShopHouse from Chipotle (CMG) seems stillborn, but the concept is a winning one. From researching Chipotle, I even knew the gents who started the joint.

But the Noodles IPO itself? Totally lost in the thicket that is the handwringing about whether the Fed is really tightening.


This is a bad sign for a stock-picker like me. We have to take advantage of the free money wherever we can find it, and that money has been in the IPO market. The Noodles deal was precisely the kind that bankers give you when you're fed up and when IPOs are being cancelled. It was a non-New York deal, meaning you had to get outside yourself, or at least outside the city, in order to know what the chain was like. Yet no one I know even talked about it because of the Fed obsession.


It was a real wake-up call that we need to get the international focus tamped and the U.S. focus ramped, no matter what -- because that's where the money is. Everything else, while not a distraction, does keep you from thinking about what really moves stocks, instead of what the old and new pros proclaim is calling the tune. You don't find Noodles by looking at the yen. You don't find Onyx by guessing about European fund flows or U.S. gross domestic product. If only life were that easy.

 

Cramer

 


Jim Cramer is a co-founder of TheStreet and contributes daily market commentary to the financial news network's sites. Follow his trades for Action Alerts PLUS, which Cramer co-manages as a charitable trust and has no positions in stocks mentioned.  

 

 

More from TheStreet.com

Jul 2, 2013 10:53AM
avatar

thestreet logo

A Noodles & Company restaurant (Noodles & Company via Facebook)Are you as tired as I am of the parlor game about what's driving this market? When I wake up these days, I look at China to get my usual dose of disappointment. Then I see how manipulated Japan is -- and in what direction it went -- and then I examine how horrible Europe is, and then I read stories about how the latest Federal Reserve guessing game is going. Only then do I look at how stocks are doing.


I am told to do all of this, in that order, by everyone I listen to. Some have told me -- people who are older and smarter than I am -- that, in order to figure out where the U.S. market will go, all I have to do is monitor Japan. Others say that China is pretty much in charge these days, and if China's banking system implodes, all bets are off. They say that, given the see-through nature of all those buildings in the major cities in China, that country is a ticking time bomb, especially if it needs to repatriate assets. Then others tell me that, if Spain and Italy turn and Europe gets going again, that means we'll be able to see a turn in China, which therefore means a turn here in the U.S.


But I keep thinking about Noodles (NDLS) and Onyx Pharma (ONXX). That's right -- I keep thinking about what would have been if I'd begun looking at things from the perspective of who has the best new restaurant chain and who has the best growth in biotech. I keep thinking, in other words, that I would now be making a heck of a lot more money if I'd been U.S.-stock-centric.


Fortunately, I had been able to see that Onyx could be a valuable piece of property. But that's only because I know Celgene (CELG) and the challenge that Onyx presents to it in multiple myeloma treatment -- and also because my mother died of kidney cancer, which gave me a personal insight that drew me to Onyx's Nexavar franchise.


But Noodles is infuriating me. Just infuriating -- and I am blaming it directly on the parlor game of international finance. I hadn't focused on this initial public offering because there was "too much going on," and because I was too worried about the 10-year U.S. Treasury. I knew this company may be the hottest concept out there, because I have a noodle bar next to me -- ramen-based -- that you can't get into, and which The New York Times says is the hottest trend. I know that the Asian ShopHouse from Chipotle (CMG) seems stillborn, but the concept is a winning one. From researching Chipotle, I even knew the gents who started the joint.

But the Noodles IPO itself? Totally lost in the thicket that is the handwringing about whether the Fed is really tightening.


This is a bad sign for a stock-picker like me. We have to take advantage of the free money wherever we can find it, and that money has been in the IPO market. The Noodles deal was precisely the kind that bankers give you when you're fed up and when IPOs are being cancelled. It was a non-New York deal, meaning you had to get outside yourself, or at least outside the city, in order to know what the chain was like. Yet no one I know even talked about it because of the Fed obsession.


It was a real wake-up call that we need to get the international focus tamped and the U.S. focus ramped, no matter what -- because that's where the money is. Everything else, while not a distraction, does keep you from thinking about what really moves stocks, instead of what the old and new pros proclaim is calling the tune. You don't find Noodles by looking at the yen. You don't find Onyx by guessing about European fund flows or U.S. gross domestic product. If only life were that easy.

 

Cramer

 


Jim Cramer is a co-founder of TheStreet and contributes daily market commentary to the financial news network's sites. Follow his trades for Action Alerts PLUS, which Cramer co-manages as a charitable trust and has no positions in stocks mentioned.  

 

 

More from TheStreet.com

Jul 2, 2013 4:58PM
avatar

thestreet logo

A Noodles & Company restaurant (Noodles & Company via Facebook)Are you as tired as I am of the parlor game about what's driving this market? When I wake up these days, I look at China to get my usual dose of disappointment. Then I see how manipulated Japan is -- and in what direction it went -- and then I examine how horrible Europe is, and then I read stories about how the latest Federal Reserve guessing game is going. Only then do I look at how stocks are doing.


I am told to do all of this, in that order, by everyone I listen to. Some have told me -- people who are older and smarter than I am -- that, in order to figure out where the U.S. market will go, all I have to do is monitor Japan. Others say that China is pretty much in charge these days, and if China's banking system implodes, all bets are off. They say that, given the see-through nature of all those buildings in the major cities in China, that country is a ticking time bomb, especially if it needs to repatriate assets. Then others tell me that, if Spain and Italy turn and Europe gets going again, that means we'll be able to see a turn in China, which therefore means a turn here in the U.S.


But I keep thinking about Noodles (NDLS) and Onyx Pharma (ONXX). That's right -- I keep thinking about what would have been if I'd begun looking at things from the perspective of who has the best new restaurant chain and who has the best growth in biotech. I keep thinking, in other words, that I would now be making a heck of a lot more money if I'd been U.S.-stock-centric.


Fortunately, I had been able to see that Onyx could be a valuable piece of property. But that's only because I know Celgene (CELG) and the challenge that Onyx presents to it in multiple myeloma treatment -- and also because my mother died of kidney cancer, which gave me a personal insight that drew me to Onyx's Nexavar franchise.


But Noodles is infuriating me. Just infuriating -- and I am blaming it directly on the parlor game of international finance. I hadn't focused on this initial public offering because there was "too much going on," and because I was too worried about the 10-year U.S. Treasury. I knew this company may be the hottest concept out there, because I have a noodle bar next to me -- ramen-based -- that you can't get into, and which The New York Times says is the hottest trend. I know that the Asian ShopHouse from Chipotle (CMG) seems stillborn, but the concept is a winning one. From researching Chipotle, I even knew the gents who started the joint.

But the Noodles IPO itself? Totally lost in the thicket that is the handwringing about whether the Fed is really tightening.


This is a bad sign for a stock-picker like me. We have to take advantage of the free money wherever we can find it, and that money has been in the IPO market. The Noodles deal was precisely the kind that bankers give you when you're fed up and when IPOs are being cancelled. It was a non-New York deal, meaning you had to get outside yourself, or at least outside the city, in order to know what the chain was like. Yet no one I know even talked about it because of the Fed obsession.


It was a real wake-up call that we need to get the international focus tamped and the U.S. focus ramped, no matter what -- because that's where the money is. Everything else, while not a distraction, does keep you from thinking about what really moves stocks, instead of what the old and new pros proclaim is calling the tune. You don't find Noodles by looking at the yen. You don't find Onyx by guessing about European fund flows or U.S. gross domestic product. If only life were that easy.

 

Cramer

 


Jim Cramer is a co-founder of TheStreet and contributes daily market commentary to the financial news network's sites. Follow his trades for Action Alerts PLUS, which Cramer co-manages as a charitable trust and has no positions in stocks mentioned.  

 

 

More from TheStreet.com

Jul 2, 2013 2:17PM
avatar

thestreet logo

A Noodles & Company restaurant (Noodles & Company via Facebook)Are you as tired as I am of the parlor game about what's driving this market? When I wake up these days, I look at China to get my usual dose of disappointment. Then I see how manipulated Japan is -- and in what direction it went -- and then I examine how horrible Europe is, and then I read stories about how the latest Federal Reserve guessing game is going. Only then do I look at how stocks are doing.


I am told to do all of this, in that order, by everyone I listen to. Some have told me -- people who are older and smarter than I am -- that, in order to figure out where the U.S. market will go, all I have to do is monitor Japan. Others say that China is pretty much in charge these days, and if China's banking system implodes, all bets are off. They say that, given the see-through nature of all those buildings in the major cities in China, that country is a ticking time bomb, especially if it needs to repatriate assets. Then others tell me that, if Spain and Italy turn and Europe gets going again, that means we'll be able to see a turn in China, which therefore means a turn here in the U.S.


But I keep thinking about Noodles (NDLS) and Onyx Pharma (ONXX). That's right -- I keep thinking about what would have been if I'd begun looking at things from the perspective of who has the best new restaurant chain and who has the best growth in biotech. I keep thinking, in other words, that I would now be making a heck of a lot more money if I'd been U.S.-stock-centric.


Fortunately, I had been able to see that Onyx could be a valuable piece of property. But that's only because I know Celgene (CELG) and the challenge that Onyx presents to it in multiple myeloma treatment -- and also because my mother died of kidney cancer, which gave me a personal insight that drew me to Onyx's Nexavar franchise.


But Noodles is infuriating me. Just infuriating -- and I am blaming it directly on the parlor game of international finance. I hadn't focused on this initial public offering because there was "too much going on," and because I was too worried about the 10-year U.S. Treasury. I knew this company may be the hottest concept out there, because I have a noodle bar next to me -- ramen-based -- that you can't get into, and which The New York Times says is the hottest trend. I know that the Asian ShopHouse from Chipotle (CMG) seems stillborn, but the concept is a winning one. From researching Chipotle, I even knew the gents who started the joint.

But the Noodles IPO itself? Totally lost in the thicket that is the handwringing about whether the Fed is really tightening.


This is a bad sign for a stock-picker like me. We have to take advantage of the free money wherever we can find it, and that money has been in the IPO market. The Noodles deal was precisely the kind that bankers give you when you're fed up and when IPOs are being cancelled. It was a non-New York deal, meaning you had to get outside yourself, or at least outside the city, in order to know what the chain was like. Yet no one I know even talked about it because of the Fed obsession.


It was a real wake-up call that we need to get the international focus tamped and the U.S. focus ramped, no matter what -- because that's where the money is. Everything else, while not a distraction, does keep you from thinking about what really moves stocks, instead of what the old and new pros proclaim is calling the tune. You don't find Noodles by looking at the yen. You don't find Onyx by guessing about European fund flows or U.S. gross domestic product. If only life were that easy.

 

Cramer

 


Jim Cramer is a co-founder of TheStreet and contributes daily market commentary to the financial news network's sites. Follow his trades for Action Alerts PLUS, which Cramer co-manages as a charitable trust and has no positions in stocks mentioned.  

 

 

More from TheStreet.com

Jul 2, 2013 10:33AM
avatar

thestreet logo

A Noodles & Company restaurant (Noodles & Company via Facebook)Are you as tired as I am of the parlor game about what's driving this market? When I wake up these days, I look at China to get my usual dose of disappointment. Then I see how manipulated Japan is -- and in what direction it went -- and then I examine how horrible Europe is, and then I read stories about how the latest Federal Reserve guessing game is going. Only then do I look at how stocks are doing.


I am told to do all of this, in that order, by everyone I listen to. Some have told me -- people who are older and smarter than I am -- that, in order to figure out where the U.S. market will go, all I have to do is monitor Japan. Others say that China is pretty much in charge these days, and if China's banking system implodes, all bets are off. They say that, given the see-through nature of all those buildings in the major cities in China, that country is a ticking time bomb, especially if it needs to repatriate assets. Then others tell me that, if Spain and Italy turn and Europe gets going again, that means we'll be able to see a turn in China, which therefore means a turn here in the U.S.


But I keep thinking about Noodles (NDLS) and Onyx Pharma (ONXX). That's right -- I keep thinking about what would have been if I'd begun looking at things from the perspective of who has the best new restaurant chain and who has the best growth in biotech. I keep thinking, in other words, that I would now be making a heck of a lot more money if I'd been U.S.-stock-centric.


Fortunately, I had been able to see that Onyx could be a valuable piece of property. But that's only because I know Celgene (CELG) and the challenge that Onyx presents to it in multiple myeloma treatment -- and also because my mother died of kidney cancer, which gave me a personal insight that drew me to Onyx's Nexavar franchise.


But Noodles is infuriating me. Just infuriating -- and I am blaming it directly on the parlor game of international finance. I hadn't focused on this initial public offering because there was "too much going on," and because I was too worried about the 10-year U.S. Treasury. I knew this company may be the hottest concept out there, because I have a noodle bar next to me -- ramen-based -- that you can't get into, and which The New York Times says is the hottest trend. I know that the Asian ShopHouse from Chipotle (CMG) seems stillborn, but the concept is a winning one. From researching Chipotle, I even knew the gents who started the joint.

But the Noodles IPO itself? Totally lost in the thicket that is the handwringing about whether the Fed is really tightening.


This is a bad sign for a stock-picker like me. We have to take advantage of the free money wherever we can find it, and that money has been in the IPO market. The Noodles deal was precisely the kind that bankers give you when you're fed up and when IPOs are being cancelled. It was a non-New York deal, meaning you had to get outside yourself, or at least outside the city, in order to know what the chain was like. Yet no one I know even talked about it because of the Fed obsession.


It was a real wake-up call that we need to get the international focus tamped and the U.S. focus ramped, no matter what -- because that's where the money is. Everything else, while not a distraction, does keep you from thinking about what really moves stocks, instead of what the old and new pros proclaim is calling the tune. You don't find Noodles by looking at the yen. You don't find Onyx by guessing about European fund flows or U.S. gross domestic product. If only life were that easy.

 

Cramer

 


Jim Cramer is a co-founder of TheStreet and contributes daily market commentary to the financial news network's sites. Follow his trades for Action Alerts PLUS, which Cramer co-manages as a charitable trust and has no positions in stocks mentioned.  

 

 

More from TheStreet.com

Jul 2, 2013 11:17AM
avatar

thestreet logo

A Noodles & Company restaurant (Noodles & Company via Facebook)Are you as tired as I am of the parlor game about what's driving this market? When I wake up these days, I look at China to get my usual dose of disappointment. Then I see how manipulated Japan is -- and in what direction it went -- and then I examine how horrible Europe is, and then I read stories about how the latest Federal Reserve guessing game is going. Only then do I look at how stocks are doing.


I am told to do all of this, in that order, by everyone I listen to. Some have told me -- people who are older and smarter than I am -- that, in order to figure out where the U.S. market will go, all I have to do is monitor Japan. Others say that China is pretty much in charge these days, and if China's banking system implodes, all bets are off. They say that, given the see-through nature of all those buildings in the major cities in China, that country is a ticking time bomb, especially if it needs to repatriate assets. Then others tell me that, if Spain and Italy turn and Europe gets going again, that means we'll be able to see a turn in China, which therefore means a turn here in the U.S.


But I keep thinking about Noodles (NDLS) and Onyx Pharma (ONXX). That's right -- I keep thinking about what would have been if I'd begun looking at things from the perspective of who has the best new restaurant chain and who has the best growth in biotech. I keep thinking, in other words, that I would now be making a heck of a lot more money if I'd been U.S.-stock-centric.


Fortunately, I had been able to see that Onyx could be a valuable piece of property. But that's only because I know Celgene (CELG) and the challenge that Onyx presents to it in multiple myeloma treatment -- and also because my mother died of kidney cancer, which gave me a personal insight that drew me to Onyx's Nexavar franchise.


But Noodles is infuriating me. Just infuriating -- and I am blaming it directly on the parlor game of international finance. I hadn't focused on this initial public offering because there was "too much going on," and because I was too worried about the 10-year U.S. Treasury. I knew this company may be the hottest concept out there, because I have a noodle bar next to me -- ramen-based -- that you can't get into, and which The New York Times says is the hottest trend. I know that the Asian ShopHouse from Chipotle (CMG) seems stillborn, but the concept is a winning one. From researching Chipotle, I even knew the gents who started the joint.

But the Noodles IPO itself? Totally lost in the thicket that is the handwringing about whether the Fed is really tightening.


This is a bad sign for a stock-picker like me. We have to take advantage of the free money wherever we can find it, and that money has been in the IPO market. The Noodles deal was precisely the kind that bankers give you when you're fed up and when IPOs are being cancelled. It was a non-New York deal, meaning you had to get outside yourself, or at least outside the city, in order to know what the chain was like. Yet no one I know even talked about it because of the Fed obsession.


It was a real wake-up call that we need to get the international focus tamped and the U.S. focus ramped, no matter what -- because that's where the money is. Everything else, while not a distraction, does keep you from thinking about what really moves stocks, instead of what the old and new pros proclaim is calling the tune. You don't find Noodles by looking at the yen. You don't find Onyx by guessing about European fund flows or U.S. gross domestic product. If only life were that easy.

 

Cramer

 


Jim Cramer is a co-founder of TheStreet and contributes daily market commentary to the financial news network's sites. Follow his trades for Action Alerts PLUS, which Cramer co-manages as a charitable trust and has no positions in stocks mentioned.  

 

 

More from TheStreet.com

Jul 2, 2013 2:21PM
avatar

thestreet logo

A Noodles & Company restaurant (Noodles & Company via Facebook)Are you as tired as I am of the parlor game about what's driving this market? When I wake up these days, I look at China to get my usual dose of disappointment. Then I see how manipulated Japan is -- and in what direction it went -- and then I examine how horrible Europe is, and then I read stories about how the latest Federal Reserve guessing game is going. Only then do I look at how stocks are doing.


I am told to do all of this, in that order, by everyone I listen to. Some have told me -- people who are older and smarter than I am -- that, in order to figure out where the U.S. market will go, all I have to do is monitor Japan. Others say that China is pretty much in charge these days, and if China's banking system implodes, all bets are off. They say that, given the see-through nature of all those buildings in the major cities in China, that country is a ticking time bomb, especially if it needs to repatriate assets. Then others tell me that, if Spain and Italy turn and Europe gets going again, that means we'll be able to see a turn in China, which therefore means a turn here in the U.S.


But I keep thinking about Noodles (NDLS) and Onyx Pharma (ONXX). That's right -- I keep thinking about what would have been if I'd begun looking at things from the perspective of who has the best new restaurant chain and who has the best growth in biotech. I keep thinking, in other words, that I would now be making a heck of a lot more money if I'd been U.S.-stock-centric.


Fortunately, I had been able to see that Onyx could be a valuable piece of property. But that's only because I know Celgene (CELG) and the challenge that Onyx presents to it in multiple myeloma treatment -- and also because my mother died of kidney cancer, which gave me a personal insight that drew me to Onyx's Nexavar franchise.


But Noodles is infuriating me. Just infuriating -- and I am blaming it directly on the parlor game of international finance. I hadn't focused on this initial public offering because there was "too much going on," and because I was too worried about the 10-year U.S. Treasury. I knew this company may be the hottest concept out there, because I have a noodle bar next to me -- ramen-based -- that you can't get into, and which The New York Times says is the hottest trend. I know that the Asian ShopHouse from Chipotle (CMG) seems stillborn, but the concept is a winning one. From researching Chipotle, I even knew the gents who started the joint.

But the Noodles IPO itself? Totally lost in the thicket that is the handwringing about whether the Fed is really tightening.


This is a bad sign for a stock-picker like me. We have to take advantage of the free money wherever we can find it, and that money has been in the IPO market. The Noodles deal was precisely the kind that bankers give you when you're fed up and when IPOs are being cancelled. It was a non-New York deal, meaning you had to get outside yourself, or at least outside the city, in order to know what the chain was like. Yet no one I know even talked about it because of the Fed obsession.


It was a real wake-up call that we need to get the international focus tamped and the U.S. focus ramped, no matter what -- because that's where the money is. Everything else, while not a distraction, does keep you from thinking about what really moves stocks, instead of what the old and new pros proclaim is calling the tune. You don't find Noodles by looking at the yen. You don't find Onyx by guessing about European fund flows or U.S. gross domestic product. If only life were that easy.

 

Cramer

 


Jim Cramer is a co-founder of TheStreet and contributes daily market commentary to the financial news network's sites. Follow his trades for Action Alerts PLUS, which Cramer co-manages as a charitable trust and has no positions in stocks mentioned.  

 

 

More from TheStreet.com

Jul 2, 2013 12:24PM
avatar

thestreet logo

A Noodles & Company restaurant (Noodles & Company via Facebook)Are you as tired as I am of the parlor game about what's driving this market? When I wake up these days, I look at China to get my usual dose of disappointment. Then I see how manipulated Japan is -- and in what direction it went -- and then I examine how horrible Europe is, and then I read stories about how the latest Federal Reserve guessing game is going. Only then do I look at how stocks are doing.


I am told to do all of this, in that order, by everyone I listen to. Some have told me -- people who are older and smarter than I am -- that, in order to figure out where the U.S. market will go, all I have to do is monitor Japan. Others say that China is pretty much in charge these days, and if China's banking system implodes, all bets are off. They say that, given the see-through nature of all those buildings in the major cities in China, that country is a ticking time bomb, especially if it needs to repatriate assets. Then others tell me that, if Spain and Italy turn and Europe gets going again, that means we'll be able to see a turn in China, which therefore means a turn here in the U.S.


But I keep thinking about Noodles (NDLS) and Onyx Pharma (ONXX). That's right -- I keep thinking about what would have been if I'd begun looking at things from the perspective of who has the best new restaurant chain and who has the best growth in biotech. I keep thinking, in other words, that I would now be making a heck of a lot more money if I'd been U.S.-stock-centric.


Fortunately, I had been able to see that Onyx could be a valuable piece of property. But that's only because I know Celgene (CELG) and the challenge that Onyx presents to it in multiple myeloma treatment -- and also because my mother died of kidney cancer, which gave me a personal insight that drew me to Onyx's Nexavar franchise.


But Noodles is infuriating me. Just infuriating -- and I am blaming it directly on the parlor game of international finance. I hadn't focused on this initial public offering because there was "too much going on," and because I was too worried about the 10-year U.S. Treasury. I knew this company may be the hottest concept out there, because I have a noodle bar next to me -- ramen-based -- that you can't get into, and which The New York Times says is the hottest trend. I know that the Asian ShopHouse from Chipotle (CMG) seems stillborn, but the concept is a winning one. From researching Chipotle, I even knew the gents who started the joint.

But the Noodles IPO itself? Totally lost in the thicket that is the handwringing about whether the Fed is really tightening.


This is a bad sign for a stock-picker like me. We have to take advantage of the free money wherever we can find it, and that money has been in the IPO market. The Noodles deal was precisely the kind that bankers give you when you're fed up and when IPOs are being cancelled. It was a non-New York deal, meaning you had to get outside yourself, or at least outside the city, in order to know what the chain was like. Yet no one I know even talked about it because of the Fed obsession.


It was a real wake-up call that we need to get the international focus tamped and the U.S. focus ramped, no matter what -- because that's where the money is. Everything else, while not a distraction, does keep you from thinking about what really moves stocks, instead of what the old and new pros proclaim is calling the tune. You don't find Noodles by looking at the yen. You don't find Onyx by guessing about European fund flows or U.S. gross domestic product. If only life were that easy.

 

Cramer

 


Jim Cramer is a co-founder of TheStreet and contributes daily market commentary to the financial news network's sites. Follow his trades for Action Alerts PLUS, which Cramer co-manages as a charitable trust and has no positions in stocks mentioned.  

 

 

More from TheStreet.com

Jul 2, 2013 5:18PM
avatar

thestreet logo

A Noodles & Company restaurant (Noodles & Company via Facebook)Are you as tired as I am of the parlor game about what's driving this market? When I wake up these days, I look at China to get my usual dose of disappointment. Then I see how manipulated Japan is -- and in what direction it went -- and then I examine how horrible Europe is, and then I read stories about how the latest Federal Reserve guessing game is going. Only then do I look at how stocks are doing.


I am told to do all of this, in that order, by everyone I listen to. Some have told me -- people who are older and smarter than I am -- that, in order to figure out where the U.S. market will go, all I have to do is monitor Japan. Others say that China is pretty much in charge these days, and if China's banking system implodes, all bets are off. They say that, given the see-through nature of all those buildings in the major cities in China, that country is a ticking time bomb, especially if it needs to repatriate assets. Then others tell me that, if Spain and Italy turn and Europe gets going again, that means we'll be able to see a turn in China, which therefore means a turn here in the U.S.


But I keep thinking about Noodles (NDLS) and Onyx Pharma (ONXX). That's right -- I keep thinking about what would have been if I'd begun looking at things from the perspective of who has the best new restaurant chain and who has the best growth in biotech. I keep thinking, in other words, that I would now be making a heck of a lot more money if I'd been U.S.-stock-centric.


Fortunately, I had been able to see that Onyx could be a valuable piece of property. But that's only because I know Celgene (CELG) and the challenge that Onyx presents to it in multiple myeloma treatment -- and also because my mother died of kidney cancer, which gave me a personal insight that drew me to Onyx's Nexavar franchise.


But Noodles is infuriating me. Just infuriating -- and I am blaming it directly on the parlor game of international finance. I hadn't focused on this initial public offering because there was "too much going on," and because I was too worried about the 10-year U.S. Treasury. I knew this company may be the hottest concept out there, because I have a noodle bar next to me -- ramen-based -- that you can't get into, and which The New York Times says is the hottest trend. I know that the Asian ShopHouse from Chipotle (CMG) seems stillborn, but the concept is a winning one. From researching Chipotle, I even knew the gents who started the joint.

But the Noodles IPO itself? Totally lost in the thicket that is the handwringing about whether the Fed is really tightening.


This is a bad sign for a stock-picker like me. We have to take advantage of the free money wherever we can find it, and that money has been in the IPO market. The Noodles deal was precisely the kind that bankers give you when you're fed up and when IPOs are being cancelled. It was a non-New York deal, meaning you had to get outside yourself, or at least outside the city, in order to know what the chain was like. Yet no one I know even talked about it because of the Fed obsession.


It was a real wake-up call that we need to get the international focus tamped and the U.S. focus ramped, no matter what -- because that's where the money is. Everything else, while not a distraction, does keep you from thinking about what really moves stocks, instead of what the old and new pros proclaim is calling the tune. You don't find Noodles by looking at the yen. You don't find Onyx by guessing about European fund flows or U.S. gross domestic product. If only life were that easy.

 

Cramer

 


Jim Cramer is a co-founder of TheStreet and contributes daily market commentary to the financial news network's sites. Follow his trades for Action Alerts PLUS, which Cramer co-manages as a charitable trust and has no positions in stocks mentioned.  

 

 

More from TheStreet.com

Jul 2, 2013 10:25AM
avatar

thestreet logo

A Noodles & Company restaurant (Noodles & Company via Facebook)Are you as tired as I am of the parlor game about what's driving this market? When I wake up these days, I look at China to get my usual dose of disappointment. Then I see how manipulated Japan is -- and in what direction it went -- and then I examine how horrible Europe is, and then I read stories about how the latest Federal Reserve guessing game is going. Only then do I look at how stocks are doing.


I am told to do all of this, in that order, by everyone I listen to. Some have told me -- people who are older and smarter than I am -- that, in order to figure out where the U.S. market will go, all I have to do is monitor Japan. Others say that China is pretty much in charge these days, and if China's banking system implodes, all bets are off. They say that, given the see-through nature of all those buildings in the major cities in China, that country is a ticking time bomb, especially if it needs to repatriate assets. Then others tell me that, if Spain and Italy turn and Europe gets going again, that means we'll be able to see a turn in China, which therefore means a turn here in the U.S.


But I keep thinking about Noodles (NDLS) and Onyx Pharma (ONXX). That's right -- I keep thinking about what would have been if I'd begun looking at things from the perspective of who has the best new restaurant chain and who has the best growth in biotech. I keep thinking, in other words, that I would now be making a heck of a lot more money if I'd been U.S.-stock-centric.


Fortunately, I had been able to see that Onyx could be a valuable piece of property. But that's only because I know Celgene (CELG) and the challenge that Onyx presents to it in multiple myeloma treatment -- and also because my mother died of kidney cancer, which gave me a personal insight that drew me to Onyx's Nexavar franchise.


But Noodles is infuriating me. Just infuriating -- and I am blaming it directly on the parlor game of international finance. I hadn't focused on this initial public offering because there was "too much going on," and because I was too worried about the 10-year U.S. Treasury. I knew this company may be the hottest concept out there, because I have a noodle bar next to me -- ramen-based -- that you can't get into, and which The New York Times says is the hottest trend. I know that the Asian ShopHouse from Chipotle (CMG) seems stillborn, but the concept is a winning one. From researching Chipotle, I even knew the gents who started the joint.

But the Noodles IPO itself? Totally lost in the thicket that is the handwringing about whether the Fed is really tightening.


This is a bad sign for a stock-picker like me. We have to take advantage of the free money wherever we can find it, and that money has been in the IPO market. The Noodles deal was precisely the kind that bankers give you when you're fed up and when IPOs are being cancelled. It was a non-New York deal, meaning you had to get outside yourself, or at least outside the city, in order to know what the chain was like. Yet no one I know even talked about it because of the Fed obsession.


It was a real wake-up call that we need to get the international focus tamped and the U.S. focus ramped, no matter what -- because that's where the money is. Everything else, while not a distraction, does keep you from thinking about what really moves stocks, instead of what the old and new pros proclaim is calling the tune. You don't find Noodles by looking at the yen. You don't find Onyx by guessing about European fund flows or U.S. gross domestic product. If only life were that easy.

 

Cramer

 


Jim Cramer is a co-founder of TheStreet and contributes daily market commentary to the financial news network's sites. Follow his trades for Action Alerts PLUS, which Cramer co-manages as a charitable trust and has no positions in stocks mentioned.  

 

 

More from TheStreet.com

Jul 2, 2013 1:41PM
avatar

thestreet logo

A Noodles & Company restaurant (Noodles & Company via Facebook)Are you as tired as I am of the parlor game about what's driving this market? When I wake up these days, I look at China to get my usual dose of disappointment. Then I see how manipulated Japan is -- and in what direction it went -- and then I examine how horrible Europe is, and then I read stories about how the latest Federal Reserve guessing game is going. Only then do I look at how stocks are doing.


I am told to do all of this, in that order, by everyone I listen to. Some have told me -- people who are older and smarter than I am -- that, in order to figure out where the U.S. market will go, all I have to do is monitor Japan. Others say that China is pretty much in charge these days, and if China's banking system implodes, all bets are off. They say that, given the see-through nature of all those buildings in the major cities in China, that country is a ticking time bomb, especially if it needs to repatriate assets. Then others tell me that, if Spain and Italy turn and Europe gets going again, that means we'll be able to see a turn in China, which therefore means a turn here in the U.S.


But I keep thinking about Noodles (NDLS) and Onyx Pharma (ONXX). That's right -- I keep thinking about what would have been if I'd begun looking at things from the perspective of who has the best new restaurant chain and who has the best growth in biotech. I keep thinking, in other words, that I would now be making a heck of a lot more money if I'd been U.S.-stock-centric.


Fortunately, I had been able to see that Onyx could be a valuable piece of property. But that's only because I know Celgene (CELG) and the challenge that Onyx presents to it in multiple myeloma treatment -- and also because my mother died of kidney cancer, which gave me a personal insight that drew me to Onyx's Nexavar franchise.


But Noodles is infuriating me. Just infuriating -- and I am blaming it directly on the parlor game of international finance. I hadn't focused on this initial public offering because there was "too much going on," and because I was too worried about the 10-year U.S. Treasury. I knew this company may be the hottest concept out there, because I have a noodle bar next to me -- ramen-based -- that you can't get into, and which The New York Times says is the hottest trend. I know that the Asian ShopHouse from Chipotle (CMG) seems stillborn, but the concept is a winning one. From researching Chipotle, I even knew the gents who started the joint.

But the Noodles IPO itself? Totally lost in the thicket that is the handwringing about whether the Fed is really tightening.


This is a bad sign for a stock-picker like me. We have to take advantage of the free money wherever we can find it, and that money has been in the IPO market. The Noodles deal was precisely the kind that bankers give you when you're fed up and when IPOs are being cancelled. It was a non-New York deal, meaning you had to get outside yourself, or at least outside the city, in order to know what the chain was like. Yet no one I know even talked about it because of the Fed obsession.


It was a real wake-up call that we need to get the international focus tamped and the U.S. focus ramped, no matter what -- because that's where the money is. Everything else, while not a distraction, does keep you from thinking about what really moves stocks, instead of what the old and new pros proclaim is calling the tune. You don't find Noodles by looking at the yen. You don't find Onyx by guessing about European fund flows or U.S. gross domestic product. If only life were that easy.

 

Cramer

 


Jim Cramer is a co-founder of TheStreet and contributes daily market commentary to the financial news network's sites. Follow his trades for Action Alerts PLUS, which Cramer co-manages as a charitable trust and has no positions in stocks mentioned.  

 

 

More from TheStreet.com

Jul 2, 2013 1:20PM
avatar

thestreet logo

A Noodles & Company restaurant (Noodles & Company via Facebook)Are you as tired as I am of the parlor game about what's driving this market? When I wake up these days, I look at China to get my usual dose of disappointment. Then I see how manipulated Japan is -- and in what direction it went -- and then I examine how horrible Europe is, and then I read stories about how the latest Federal Reserve guessing game is going. Only then do I look at how stocks are doing.


I am told to do all of this, in that order, by everyone I listen to. Some have told me -- people who are older and smarter than I am -- that, in order to figure out where the U.S. market will go, all I have to do is monitor Japan. Others say that China is pretty much in charge these days, and if China's banking system implodes, all bets are off. They say that, given the see-through nature of all those buildings in the major cities in China, that country is a ticking time bomb, especially if it needs to repatriate assets. Then others tell me that, if Spain and Italy turn and Europe gets going again, that means we'll be able to see a turn in China, which therefore means a turn here in the U.S.


But I keep thinking about Noodles (NDLS) and Onyx Pharma (ONXX). That's right -- I keep thinking about what would have been if I'd begun looking at things from the perspective of who has the best new restaurant chain and who has the best growth in biotech. I keep thinking, in other words, that I would now be making a heck of a lot more money if I'd been U.S.-stock-centric.


Fortunately, I had been able to see that Onyx could be a valuable piece of property. But that's only because I know Celgene (CELG) and the challenge that Onyx presents to it in multiple myeloma treatment -- and also because my mother died of kidney cancer, which gave me a personal insight that drew me to Onyx's Nexavar franchise.


But Noodles is infuriating me. Just infuriating -- and I am blaming it directly on the parlor game of international finance. I hadn't focused on this initial public offering because there was "too much going on," and because I was too worried about the 10-year U.S. Treasury. I knew this company may be the hottest concept out there, because I have a noodle bar next to me -- ramen-based -- that you can't get into, and which The New York Times says is the hottest trend. I know that the Asian ShopHouse from Chipotle (CMG) seems stillborn, but the concept is a winning one. From researching Chipotle, I even knew the gents who started the joint.

But the Noodles IPO itself? Totally lost in the thicket that is the handwringing about whether the Fed is really tightening.


This is a bad sign for a stock-picker like me. We have to take advantage of the free money wherever we can find it, and that money has been in the IPO market. The Noodles deal was precisely the kind that bankers give you when you're fed up and when IPOs are being cancelled. It was a non-New York deal, meaning you had to get outside yourself, or at least outside the city, in order to know what the chain was like. Yet no one I know even talked about it because of the Fed obsession.


It was a real wake-up call that we need to get the international focus tamped and the U.S. focus ramped, no matter what -- because that's where the money is. Everything else, while not a distraction, does keep you from thinking about what really moves stocks, instead of what the old and new pros proclaim is calling the tune. You don't find Noodles by looking at the yen. You don't find Onyx by guessing about European fund flows or U.S. gross domestic product. If only life were that easy.

 

Cramer

 


Jim Cramer is a co-founder of TheStreet and contributes daily market commentary to the financial news network's sites. Follow his trades for Action Alerts PLUS, which Cramer co-manages as a charitable trust and has no positions in stocks mentioned.  

 

 

More from TheStreet.com

Jul 2, 2013 2:54PM
avatar

thestreet logo

A Noodles & Company restaurant (Noodles & Company via Facebook)Are you as tired as I am of the parlor game about what's driving this market? When I wake up these days, I look at China to get my usual dose of disappointment. Then I see how manipulated Japan is -- and in what direction it went -- and then I examine how horrible Europe is, and then I read stories about how the latest Federal Reserve guessing game is going. Only then do I look at how stocks are doing.


I am told to do all of this, in that order, by everyone I listen to. Some have told me -- people who are older and smarter than I am -- that, in order to figure out where the U.S. market will go, all I have to do is monitor Japan. Others say that China is pretty much in charge these days, and if China's banking system implodes, all bets are off. They say that, given the see-through nature of all those buildings in the major cities in China, that country is a ticking time bomb, especially if it needs to repatriate assets. Then others tell me that, if Spain and Italy turn and Europe gets going again, that means we'll be able to see a turn in China, which therefore means a turn here in the U.S.


But I keep thinking about Noodles (NDLS) and Onyx Pharma (ONXX). That's right -- I keep thinking about what would have been if I'd begun looking at things from the perspective of who has the best new restaurant chain and who has the best growth in biotech. I keep thinking, in other words, that I would now be making a heck of a lot more money if I'd been U.S.-stock-centric.


Fortunately, I had been able to see that Onyx could be a valuable piece of property. But that's only because I know Celgene (CELG) and the challenge that Onyx presents to it in multiple myeloma treatment -- and also because my mother died of kidney cancer, which gave me a personal insight that drew me to Onyx's Nexavar franchise.


But Noodles is infuriating me. Just infuriating -- and I am blaming it directly on the parlor game of international finance. I hadn't focused on this initial public offering because there was "too much going on," and because I was too worried about the 10-year U.S. Treasury. I knew this company may be the hottest concept out there, because I have a noodle bar next to me -- ramen-based -- that you can't get into, and which The New York Times says is the hottest trend. I know that the Asian ShopHouse from Chipotle (CMG) seems stillborn, but the concept is a winning one. From researching Chipotle, I even knew the gents who started the joint.

But the Noodles IPO itself? Totally lost in the thicket that is the handwringing about whether the Fed is really tightening.


This is a bad sign for a stock-picker like me. We have to take advantage of the free money wherever we can find it, and that money has been in the IPO market. The Noodles deal was precisely the kind that bankers give you when you're fed up and when IPOs are being cancelled. It was a non-New York deal, meaning you had to get outside yourself, or at least outside the city, in order to know what the chain was like. Yet no one I know even talked about it because of the Fed obsession.


It was a real wake-up call that we need to get the international focus tamped and the U.S. focus ramped, no matter what -- because that's where the money is. Everything else, while not a distraction, does keep you from thinking about what really moves stocks, instead of what the old and new pros proclaim is calling the tune. You don't find Noodles by looking at the yen. You don't find Onyx by guessing about European fund flows or U.S. gross domestic product. If only life were that easy.

 

Cramer

 


Jim Cramer is a co-founder of TheStreet and contributes daily market commentary to the financial news network's sites. Follow his trades for Action Alerts PLUS, which Cramer co-manages as a charitable trust and has no positions in stocks mentioned.  

 

 

More from TheStreet.com

Jul 2, 2013 2:44PM
avatar

thestreet logo

A Noodles & Company restaurant (Noodles & Company via Facebook)Are you as tired as I am of the parlor game about what's driving this market? When I wake up these days, I look at China to get my usual dose of disappointment. Then I see how manipulated Japan is -- and in what direction it went -- and then I examine how horrible Europe is, and then I read stories about how the latest Federal Reserve guessing game is going. Only then do I look at how stocks are doing.


I am told to do all of this, in that order, by everyone I listen to. Some have told me -- people who are older and smarter than I am -- that, in order to figure out where the U.S. market will go, all I have to do is monitor Japan. Others say that China is pretty much in charge these days, and if China's banking system implodes, all bets are off. They say that, given the see-through nature of all those buildings in the major cities in China, that country is a ticking time bomb, especially if it needs to repatriate assets. Then others tell me that, if Spain and Italy turn and Europe gets going again, that means we'll be able to see a turn in China, which therefore means a turn here in the U.S.


But I keep thinking about Noodles (NDLS) and Onyx Pharma (ONXX). That's right -- I keep thinking about what would have been if I'd begun looking at things from the perspective of who has the best new restaurant chain and who has the best growth in biotech. I keep thinking, in other words, that I would now be making a heck of a lot more money if I'd been U.S.-stock-centric.


Fortunately, I had been able to see that Onyx could be a valuable piece of property. But that's only because I know Celgene (CELG) and the challenge that Onyx presents to it in multiple myeloma treatment -- and also because my mother died of kidney cancer, which gave me a personal insight that drew me to Onyx's Nexavar franchise.


But Noodles is infuriating me. Just infuriating -- and I am blaming it directly on the parlor game of international finance. I hadn't focused on this initial public offering because there was "too much going on," and because I was too worried about the 10-year U.S. Treasury. I knew this company may be the hottest concept out there, because I have a noodle bar next to me -- ramen-based -- that you can't get into, and which The New York Times says is the hottest trend. I know that the Asian ShopHouse from Chipotle (CMG) seems stillborn, but the concept is a winning one. From researching Chipotle, I even knew the gents who started the joint.

But the Noodles IPO itself? Totally lost in the thicket that is the handwringing about whether the Fed is really tightening.


This is a bad sign for a stock-picker like me. We have to take advantage of the free money wherever we can find it, and that money has been in the IPO market. The Noodles deal was precisely the kind that bankers give you when you're fed up and when IPOs are being cancelled. It was a non-New York deal, meaning you had to get outside yourself, or at least outside the city, in order to know what the chain was like. Yet no one I know even talked about it because of the Fed obsession.


It was a real wake-up call that we need to get the international focus tamped and the U.S. focus ramped, no matter what -- because that's where the money is. Everything else, while not a distraction, does keep you from thinking about what really moves stocks, instead of what the old and new pros proclaim is calling the tune. You don't find Noodles by looking at the yen. You don't find Onyx by guessing about European fund flows or U.S. gross domestic product. If only life were that easy.

 

Cramer

 


Jim Cramer is a co-founder of TheStreet and contributes daily market commentary to the financial news network's sites. Follow his trades for Action Alerts PLUS, which Cramer co-manages as a charitable trust and has no positions in stocks mentioned.  

 

 

More from TheStreet.com

avatar

thestreet logo

A Noodles & Company restaurant (Noodles & Company via Facebook)Are you as tired as I am of the parlor game about what's driving this market? When I wake up these days, I look at China to get my usual dose of disappointment. Then I see how manipulated Japan is -- and in what direction it went -- and then I examine how horrible Europe is, and then I read stories about how the latest Federal Reserve guessing game is going. Only then do I look at how stocks are doing.


I am told to do all of this, in that order, by everyone I listen to. Some have told me -- people who are older and smarter than I am -- that, in order to figure out where the U.S. market will go, all I have to do is monitor Japan. Others say that China is pretty much in charge these days, and if China's banking system implodes, all bets are off. They say that, given the see-through nature of all those buildings in the major cities in China, that country is a ticking time bomb, especially if it needs to repatriate assets. Then others tell me that, if Spain and Italy turn and Europe gets going again, that means we'll be able to see a turn in China, which therefore means a turn here in the U.S.


But I keep thinking about Noodles (NDLS) and Onyx Pharma (ONXX). That's right -- I keep thinking about what would have been if I'd begun looking at things from the perspective of who has the best new restaurant chain and who has the best growth in biotech. I keep thinking, in other words, that I would now be making a heck of a lot more money if I'd been U.S.-stock-centric.


Fortunately, I had been able to see that Onyx could be a valuable piece of property. But that's only because I know Celgene (CELG) and the challenge that Onyx presents to it in multiple myeloma treatment -- and also because my mother died of kidney cancer, which gave me a personal insight that drew me to Onyx's Nexavar franchise.


But Noodles is infuriating me. Just infuriating -- and I am blaming it directly on the parlor game of international finance. I hadn't focused on this initial public offering because there was "too much going on," and because I was too worried about the 10-year U.S. Treasury. I knew this company may be the hottest concept out there, because I have a noodle bar next to me -- ramen-based -- that you can't get into, and which The New York Times says is the hottest trend. I know that the Asian ShopHouse from Chipotle (CMG) seems stillborn, but the concept is a winning one. From researching Chipotle, I even knew the gents who started the joint.

But the Noodles IPO itself? Totally lost in the thicket that is the handwringing about whether the Fed is really tightening.


This is a bad sign for a stock-picker like me. We have to take advantage of the free money wherever we can find it, and that money has been in the IPO market. The Noodles deal was precisely the kind that bankers give you when you're fed up and when IPOs are being cancelled. It was a non-New York deal, meaning you had to get outside yourself, or at least outside the city, in order to know what the chain was like. Yet no one I know even talked about it because of the Fed obsession.


It was a real wake-up call that we need to get the international focus tamped and the U.S. focus ramped, no matter what -- because that's where the money is. Everything else, while not a distraction, does keep you from thinking about what really moves stocks, instead of what the old and new pros proclaim is calling the tune. You don't find Noodles by looking at the yen. You don't find Onyx by guessing about European fund flows or U.S. gross domestic product. If only life were that easy.

 

Cramer

 


Jim Cramer is a co-founder of TheStreet and contributes daily market commentary to the financial news network's sites. Follow his trades for Action Alerts PLUS, which Cramer co-manages as a charitable trust and has no positions in stocks mentioned.  

 

 

More from TheStreet.com

Jul 2, 2013 10:47AM
avatar

thestreet logo

A Noodles & Company restaurant (Noodles & Company via Facebook)Are you as tired as I am of the parlor game about what's driving this market? When I wake up these days, I look at China to get my usual dose of disappointment. Then I see how manipulated Japan is -- and in what direction it went -- and then I examine how horrible Europe is, and then I read stories about how the latest Federal Reserve guessing game is going. Only then do I look at how stocks are doing.


I am told to do all of this, in that order, by everyone I listen to. Some have told me -- people who are older and smarter than I am -- that, in order to figure out where the U.S. market will go, all I have to do is monitor Japan. Others say that China is pretty much in charge these days, and if China's banking system implodes, all bets are off. They say that, given the see-through nature of all those buildings in the major cities in China, that country is a ticking time bomb, especially if it needs to repatriate assets. Then others tell me that, if Spain and Italy turn and Europe gets going again, that means we'll be able to see a turn in China, which therefore means a turn here in the U.S.


But I keep thinking about Noodles (NDLS) and Onyx Pharma (ONXX). That's right -- I keep thinking about what would have been if I'd begun looking at things from the perspective of who has the best new restaurant chain and who has the best growth in biotech. I keep thinking, in other words, that I would now be making a heck of a lot more money if I'd been U.S.-stock-centric.


Fortunately, I had been able to see that Onyx could be a valuable piece of property. But that's only because I know Celgene (CELG) and the challenge that Onyx presents to it in multiple myeloma treatment -- and also because my mother died of kidney cancer, which gave me a personal insight that drew me to Onyx's Nexavar franchise.


But Noodles is infuriating me. Just infuriating -- and I am blaming it directly on the parlor game of international finance. I hadn't focused on this initial public offering because there was "too much going on," and because I was too worried about the 10-year U.S. Treasury. I knew this company may be the hottest concept out there, because I have a noodle bar next to me -- ramen-based -- that you can't get into, and which The New York Times says is the hottest trend. I know that the Asian ShopHouse from Chipotle (CMG) seems stillborn, but the concept is a winning one. From researching Chipotle, I even knew the gents who started the joint.

But the Noodles IPO itself? Totally lost in the thicket that is the handwringing about whether the Fed is really tightening.


This is a bad sign for a stock-picker like me. We have to take advantage of the free money wherever we can find it, and that money has been in the IPO market. The Noodles deal was precisely the kind that bankers give you when you're fed up and when IPOs are being cancelled. It was a non-New York deal, meaning you had to get outside yourself, or at least outside the city, in order to know what the chain was like. Yet no one I know even talked about it because of the Fed obsession.


It was a real wake-up call that we need to get the international focus tamped and the U.S. focus ramped, no matter what -- because that's where the money is. Everything else, while not a distraction, does keep you from thinking about what really moves stocks, instead of what the old and new pros proclaim is calling the tune. You don't find Noodles by looking at the yen. You don't find Onyx by guessing about European fund flows or U.S. gross domestic product. If only life were that easy.

 

Cramer

 


Jim Cramer is a co-founder of TheStreet and contributes daily market commentary to the financial news network's sites. Follow his trades for Action Alerts PLUS, which Cramer co-manages as a charitable trust and has no positions in stocks mentioned.  

 

 

More from TheStreet.com

Report
Please help us to maintain a healthy and vibrant community by reporting any illegal or inappropriate behavior. If you believe a message violates theCode of Conductplease use this form to notify the moderators. They will investigate your report and take appropriate action. If necessary, they report all illegal activity to the proper authorities.
Categories
100 character limit
Are you sure you want to delete this comment?

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

STOCK SCOUTER

StockScouter rates stocks from 1 to 10, with 10 being the best, using a system of advanced mathematics to determine a stock's expected risk and return. Ratings are displayed on a bell curve, meaning there will be fewer ratings of 1 and 10 and far more of 4 through 7.

123
123 rated 1
266
266 rated 2
485
485 rated 3
660
660 rated 4
586
586 rated 5
652
652 rated 6
640
640 rated 7
504
504 rated 8
289
289 rated 9
159
159 rated 10
12345678910

Top Picks

SYMBOLNAMERATING
TAT&T Inc9
VZVERIZON COMMUNICATIONS8
CTLCENTURYLINK Inc8
EXCEXELON CORPORATION8
AAPLAPPLE Inc10
More

VIDEO ON MSN MONEY

ABOUT

Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.

Contributors include professional investors and journalists affiliated with MSN Money.

Follow us on Twitter @topstocksmsn.